Rational design of Salmonella recombinant vaccines

被引：53

作者：

Cheminay, Cedric ^{[2
]}

Hensel, Michael ^{[1
]}

机构：

[1] Univ Klinikum Erlangen, Inst Mikrobiol, D-91054 Erlangen, Germany

[2] LMU Munchen, Inst Immunol, Munich, Germany

来源：

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2008年 / 298卷 / 1-2期

关键词：

live attenuated vaccines; Salmonella pathogenesis; recombinant vaccines;

D O I：

10.1016/j.ijmm.2007.08.006

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Salmonella enterica is an important pathogen of animals and humans causing a variety of infectious diseases. The large number of cases of typhoid fever due to S. enterica serovar Typhi infections gives rise to the continuous need for improved vaccines against this life-threatening infection. However, S. enterica is also an interesting organism to act as a live attenuated carrier for the presentation of recombinant heterologous antigens. Comprehensive experimental studies have been performed and a detailed knowledge of the molecular mechanisms of important virulence factors is available. This allows the rationale design of improved Salmonella carrier strains and the development of novel strategies for the expression and presentation of recombinant antigens. Here, we review recent advances in generation of live attenuated Salmonella vaccines and discuss criteria for expression strategies of heterologous antigens by Salmonella carrier strains. (C) 2007 Elsevier GmbH. All rights reserved.

引用

页码：87 / 98

页数：12

共 108 条

[31] Salmonella DNA adenine methylase mutants confer cross-protective immunity [J].

Heithoff, DM ;

Enioutina, EY ;

Daynes, RA ;

Sinsheimer, RL ;

Low, DA ;

Mahan, MJ .

INFECTION AND IMMUNITY, 2001, 69 (11) :6725-6730

[32] Evolution of pathogenicity islands of Salmonella enterica [J].

Hensel, M .

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 (2-3) :95-102

[33] SIMULTANEOUS IDENTIFICATION OF BACTERIAL VIRULENCE GENES BY NEGATIVE SELECTION [J].

HENSEL, M ;

SHEA, JE ;

GLEESON, C ;

JONES, MD ;

DALTON, E ;

HOLDEN, DW .

SCIENCE, 1995, 269 (5222) :400-403

[34] Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis [J].

Hess, J ;

Gentschev, I ;

Miko, D ;

Welzel, M ;

Ladel, C ;

Goebel, W ;

Kaufmann, SHE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1458-1463

[35] MACROPHAGE-INDUCIBLE EXPRESSION OF A MODEL ANTIGEN IN SALMONELLA-TYPHIMURIUM ENHANCES IMMUNOGENICITY [J].

HOHMANN, EL ;

OLETTA, CA ;

LOOMIS, WP ;

MILLER, SI .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2904-2908

[36] phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers [J].

Hohmann, EL ;

Oletta, CA ;

Killeen, KP ;

Miller, SI .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1408-1414

[37] EVALUATION IN VOLUNTEERS OF A CANDIDATE LIVE ORAL ATTENUATED SALMONELLA-TYPHI VECTOR VACCINE [J].

HONE, DM ;

TACKET, CO ;

HARRIS, AM ;

KAY, B ;

LOSONSKY, G ;

LEVINE, MM .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :412-420

[38]

Hopkins SA, 2000, CELL MICROBIOL, V2, P59

[39]

Humphreys S, 1999, INFECT IMMUN, V67, P1560

[40] Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines [J].

Husseiny, MI ;

Hensel, M .

VACCINE, 2005, 23 (20) :2580-2590

← 1 2 3 4 5 6 7 8 9 10 →